Celgene (CELG) Income Statement

Click line-items for a historical chart and %

Revenue:
Net product sales	2.97B
Collaborative agreements and other revenue	14.2M
Royalty revenue
Total revenue	2.98B
Expenses:
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development	1.65B
Selling, general and administrative	698M
Amortization of acquired intangible assets
Acquisition related (gains) charges and restructuring, net	25M
Total costs and expenses	2.57B
Operating income	411.5M
Other income and expense:
Interest and investment income, net	7.3M
Equity in (gains) losses of affiliated companies
Interest expense	-127.8M
Other income, net	-34.2M
Income before income taxes	256.8M
Income tax provision	85.4M
Net income	171.4M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic	0.22
Diluted	0.21
Weighted average shares:
Basic	775.8M
Diluted	801.5M

Entities mentioned with CELG